ArticleTargeted oncology2016

Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status.

Florence Huguet et al.PubMed ↗Publisher ↗

No numbers read from the abstract.